Lupus Nephritis

Childhood-Onset Lupus Nephritis Linked With Adverse Outcomes

Publish Date December 19, 2022

Early diagnosis and treatment of childhood-onset systemic lupus erythematosus is important to prevent lupus nephritis outcomes such as end-stage kidney disease.

Lupus Nephritis Remission Predicted by Artificial Neural Network

Publish Date December 14, 2022

With further validation, the artificial neural network may be used in clinical practice for lupus nephritis management.

ACR: Long-Term Safety Demonstrated for Anifrolumab in Lupus

Publish Date December 6, 2022

Exposure-adjusted incidence rates of serious adverse events 8.5 versus 11.2 per 100 patient-years for anifrolumab versus placebo

ACR: Low-Dose Hydroxychloroquine Tied to More Hospitalizations for Lupus Flares

Publish Date November 30, 2022

Both weight-based and non-weight-based low-dose HCQ associated with increased hospitalizations for SLE

Belimumab Efficacy for Lupus Nephritis Maintained Beyond 2 Years

Publish Date November 28, 2022

Belimumab treatment continued to protect the kidneys in adults with active lupus nephritis.

Lupus Nephritis Drug Voclosporin Shows Efficacy, Safety Over 3 Years

Publish Date November 22, 2022

One study focused on patients with severe lupus nephritis, who are at greatest risk for kidney failure.

History of Serious Infection Strongly Predicts Serious Infection in SLE

Publish Date October 24, 2022

Predictors of serious infection among patients with SLE were evaluated in a prospective study.

Lupus Anticoagulant Levels May Predict Cardiac Dysfunction in Patients With SLE

Publish Date October 20, 2022

In a 5-year follow-up study, researchers identified the characteristics associated with cardiac function in patients with systemic lupus erythematosus.

COVID-19 Vaccines Not Associated With Increased Risk for SLE Flares

Publish Date October 13, 2022

The aim of the study was to evaluate the occurrence of SLE flares after COVID-19 vaccination.

SLE Flare Can Still Occur After Dialysis Initiation

Publish Date October 6, 2022

In a study of 121 patients with lupus nephritis on dialysis, 26.4% experienced an SLE flare at a median of 17 months after dialysis initiation.